This article is more than 5 years old. Information may no longer be current.

Zimmer Biomet receives FDA 510(k) clearance for spine system intended for robotically assisted surgeries

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Zimmer Biomet Holdings Inc. announced it received FDA 510(k) clearance for the Rosa One Spine System, which is intended for robotically assisted minimally invasive and complex spine surgeries.

According to a company press release, Rosa One Spine combines robotics and navigation to delivers a real-time patient dynamic-tracking capability. It also features 3-D intraoperative planning software to improve the accuracy and predictability of implant and instrument placement.

“Rosa One Spine functions as a dual robotics and navigation technology solution for minimally invasive and complex thoracolumbar spine procedures,” Aure Bruneau, Zimmer Biomet's group president of spine, CMF and thoracic and surgery-assisting technology, said in the release. “We are extremely excited about the addition of Rosa One Spine to our already released Rosa One Brain and Rosa Knee Systems.”

Reference:

investor.zimmerbiomet.com/news-and-events/news/2019/03-25-2019-110123399